Tuesday, April 30, 2024
This conference has already taken place.
Description
Antithrombotic reversal strategies should be limited to clinical situations (i.e. life-threatening bleeding) where the immediate need for anticoagulant reversal outweighs the risk of thrombosis (either from the reversal agent itself or normalization of coagulation in a patient with underlying thromboembolic risk). This session of the APP Boot Camp Series will review anticoagulation reversal therapy and potential complications.
Dates and Times
Start: 4/30/2024 12:00 PM
End: 4/30/2024 1:00 PM
Objectives
At the conclusion of this continuing medical education activity participations should be able to:
1. Review anticoagulant reversal therapy guidelines;
2. Discuss possible complications of anticoagulant reversal therapy.
Pricing
| Tier | Price |
|---|---|
| Physician | $0.00 |
| Physician Assistant | $0.00 |
| Nurse/Nurse Practitioner | $0.00 |
| Allied Health Professional | $0.00 |
| Other | $0.00 |
Speakers
Accreditation Statement
The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The Ohio State University designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.